Stempoint Capital’s uniQure QURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Buy
88,115
+10,049
+13% +$263K 0.7% 41
2026
Q1
$1.28M Buy
78,066
+34,581
+80% +$700K 0.24% 62
2025
Q4
$1.04M Sell
43,485
-478,670
-92% -$18.5M 0.18% 68
2025
Q3
$30.5M Sell
522,155
-50,460
-9% -$916K 6.11% 2
2025
Q2
$7.98M Sell
572,615
-158,424
-22% -$2.13M 2.56% 16
2025
Q1
$7.75M Buy
731,039
+641,039
+712% +$8.99M 2.47% 14
2024
Q4
$1.59M Buy
+90,000
New +$777K 0.4% 43

Other funds holding QURE

Stempoint Capital's QURE Position: Q2 2026 in Review

Stempoint Capital increased its uniQure (QURE) stake by 13% in Q2 2026, buying an estimated $263K and bringing the position to 88,115 shares worth $4.06M. The position accounts for 0.7% of the portfolio, ranked #41.

Stempoint Capital first reported a position in QURE in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.5M in Q3 2025. 255 funds tracked by Wall St. Rank hold QURE as of Q2 2026.

  • Stempoint Capital held 88,115 shares of uniQure worth $4.06M as of Q2 2026.
  • Stempoint Capital bought 10,049 uniQure shares in Q2 2026, an estimated $263K.
  • uniQure made up 0.7% of Stempoint Capital's portfolio in Q2 2026, its #41 holding.
  • Stempoint Capital first reported a position in uniQure in Q4 2024 and has held it in 7 quarters since.
  • Stempoint Capital's uniQure position peaked at $30.5M in Q3 2025.
  • 255 funds tracked by Wall St. Rank held uniQure as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.